REMAP-CAP TRIAL OF CONVALESCENT PLASMA IN COVID-19 PAUSES ENROLMENT OF CRITICALLY ILL PATIENTS REQUIRING INTENSIVE CARE
Remap-Cap Trial Of Convalescent Plasma In Covid-19 Pauses Enrolment Of Critically Ill Patients Requiring Intensive Care
![Reuters logo](/images/reuters.jpg)
REMAP-CAP TRIAL OF CONVALESCENT PLASMA IN COVID-19 PAUSES ENROLMENT OF CRITICALLY ILL PATIENTS REQUIRING INTENSIVE CARE